Dr. C. Linn Cadieux, center, a research chemist with the U.S. Army Medical Research Institute of Chemical Defense Medical Toxicology Research Division, led the development of a new model for testing nerve agent exposure and drug efficacy that promises to accelerate the fielding of the next generation of nerve agent countermeasures. Dr. Nicholas Paparoidamis, left, and Dr. Robert diTargiani oversaw the development of crucial elements of the model that ensured its success. (photo credit: USAMRICD Visual Information Office)
| Date Taken: | 08.25.2025 |
| Date Posted: | 02.06.2026 15:24 |
| Photo ID: | 9510292 |
| VIRIN: | 250825-O-SP814-5652 |
| Resolution: | 6720x4480 |
| Size: | 5.44 MB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 2 |
| Downloads: | 0 |
This work, USAMRICD Completes Landmark Nerve Agent Treatment Project, by Anna Applegate, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
